NCT07239362 is a NA clinical trial of Culturally adapted DBT in Borderline Personality Disorder (BPD), sponsored by Pakistan Association of Cognitive Therapists.

Who is sponsoring NCT07239362?

NCT07239362 is sponsored by Pakistan Association of Cognitive Therapists.

What drugs are being tested in NCT07239362?

Interventions in NCT07239362: Culturally adapted DBT.

What condition does NCT07239362 study?

NCT07239362 studies Borderline Personality Disorder (BPD), Dialectical Behavior Therapy, Emotional Dysregulation, Self Harm, Suicidal and Self-injurious Behavior, Depression Anxiety Disorder.

Is NCT07239362 still recruiting?

NCT07239362 is currently not yet recruiting. Last updated 28 November 2025.

Last reviewed 2025-11-28 · How we verify

NCT07239362

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CULTURALLY ADAPTED DIALECTICAL BEHAVIOR THERAPY FOR LOW-MIDDLE-INCOME COUNTRIES

Not yet recruiting NA Last updated 28 November 2025

What this trial tests

NA trial testing Culturally adapted DBT in Borderline Personality Disorder (BPD) in 220 participants. Not yet recruiting.

Timeline

20 November 2025

Primary endpoint
1 June 2026

31 July 2026

Quick facts

Lead sponsor	Pakistan Association of Cognitive Therapists
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	220
Start date	20 November 2025
Primary completion	1 June 2026
Estimated completion	31 July 2026
Sites	1 location across Pakistan

Drugs / interventions tested

Culturally adapted DBT

Conditions studied

Borderline Personality Disorder (BPD) — all drugs for Borderline Personality Disorder (BPD) →
Dialectical Behavior Therapy — all drugs for Dialectical Behavior Therapy →
Emotional Dysregulation — all drugs for Emotional Dysregulation →
Self Harm — all drugs for Self Harm →

Sponsor

Pakistan Association of Cognitive Therapists

Who can join

Adults 18 to 45, any sex, with Borderline Personality Disorder (BPD) or Dialectical Behavior Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to assess the efficacy of culturally adapted dialectical behaviour therapy (DBT) for addressing emotional dysregulation in a low- and middle-income country, as well as to evaluate the impact of DBT on secondary outcomes such as borderline personality traits, self-harm or suicide, depression, anxiety, and individuals' functioning and disability. Through a rigorous Randomised Controlled Trial (RCT), the research seeks to assess how cultural adaptations of dialectical behaviour therapy improve its applicability, engagement, and outcomes in diverse socio-cultural settings, contributing to more accessible and effective mental health interventions in resource-limited regions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Borderline Personality Disorder (BPD)

Currently open trials in the same condition.

NCT07341438 — Physical Activity in the Management of Personality Disorders · NA · recruiting
NCT06699732 — Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patient · NA · recruiting
NCT06195553 — Application and Effectiveness of the STEPPS in Patients with BPD, Extending to Their Families with the FC Program · NA · recruiting

Other Pakistan Association of Cognitive Therapists trials

Trials by the same sponsor.

NCT07236164 — Effectiveness of a Guided Self-Help CBT Manual 'KOK' in Cancer Patients · NA · not yet recruiting
NCT06646900 — Feasibility and Acceptability Trial of a Culturally Adapted Manual Versus Standard CBT Manual: A Randomized Control Tria · NA · recruiting
NCT07232823 — Brief Culturally Adapted CBT for OCD · NA · recruiting
NCT06591663 — Can Cognitive Therapy Rating Scale (CTRS) be Used Across Cultures? Enhancing Cultural Relevance of CTRS · NA · recruiting
NCT06591676 — Translation and Cultural Adaptation of the Dysfunctional Attitude Scale (DAS) Into Urdu · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07239362 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pakistan Association of Cognitive Therapists
Last refreshed: 28 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07239362.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing